← Leaderboards
Jane C. Figueiredo
University Of Southern California
$16,710,015
Attributed
$48,805,382
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.1M · FY2009–25$20M$15M$10M$5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$57,904,994 · 17
By mechanism
U01$28,113,060 · 2
R01$17,344,053 · 6
U54$11,981,797 · 7
P50$303,543 · 1
R03$162,541 · 1
Top collaborators
- Cornelia M Ulrich13 shared
- Adetunji T Toriola10 shared
- Michael Karin8 shared
- Stephanie L. Schmit8 shared
- David Shibata8 shared
- Erin Siegel8 shared
- Akil Merchant7 shared
- Biljana Gigic6 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Robert William Haile$42,901,503
- David V Conti$11,852,017
- Darby E. Saxbe$2,316,888
- Duncan C. Thomas$10,473,091
- Fredrick Ray Schumacher$3,764,609
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsResourcesCohortColorectal CancerParticipantCommunitiesDiagnosisInnovationProspectiveRecruitWomanCharacteristicsEnrollmentTumorBaseBiobankFundingSiteCohort StudiesCollaborationsCessation Of LifeMolecularBehavioralAffect
Grant awards (57)
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,724,414
U01 · FY2025 · CA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators$766,963
R01 · FY2025 · CA · contact PI
Persistent Poverty and Colorectal Cancer Risk: Elucidating biological, behavioral, and place-based pathways$724,840
R01 · FY2025 · CA
Elucidating the role of transcriptomics in driving ethnicity and ancestry-related disparities in colorectal cancer$664,795
R01 · FY2025 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$95,364
U01 · FY2025 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$91,144
U01 · FY2025 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,788,840
U01 · FY2024 · CA
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2$989,284
U54 · FY2024 · CA · contact PI
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators$841,251
R01 · FY2024 · CA · contact PI
Elucidating the role of transcriptomics in driving ethnicity and ancestry-related disparities in colorectal cancer$719,426
R01 · FY2024 · CA · contact PI
Novel Biomarkers for Cancer-Related Fatigue: Integrating Metabolomics, Genomics and Behaviors$659,219
R01 · FY2024 · NR · contact PI
Project 4: Effect of Meal Timing during Cancer Treatment in Alaska Native Patients - A Randomized Clinical Trial$303,543
P50 · FY2024 · CA · contact PI
Biological determinants of colorectal cancer outcomes in Latinos of diverseýancestral origins$120,730
R01 · FY2024 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$95,210
U01 · FY2024 · CA
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2$2,350,878
U54 · FY2023 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,848,714
U01 · FY2023 · CA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators$867,802
R01 · FY2023 · CA · contact PI
Novel Biomarkers for Cancer-Related Fatigue: Integrating Metabolomics, Genomics and Behaviors$661,957
R01 · FY2023 · NR · contact PI
Biological determinants of colorectal cancer outcomes in Latinos of diverseýancestral origins$458,639
R01 · FY2023 · CA
Colon Cancer Family Registry Cohort$1,868,610
U01 · FY2022 · CA
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2$1,738,155
U54 · FY2022 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,670,811
U01 · FY2022 · CA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators$867,802
R01 · FY2022 · CA · contact PI
Novel Biomarkers for Cancer-Related Fatigue: Integrating Metabolomics, Genomics and Behaviors$664,970
R01 · FY2022 · NR · contact PI
Biological determinants of colorectal cancer outcomes in Latinos of diverseýancestral origins$584,261
R01 · FY2022 · CA
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2$440,000
U54 · FY2022 · CA · contact PI
Admin-Core-001$440,000
U54 · FY2022 · CA · contact PI
CORALE-SeroNet Recruitment and Biobanking Core$396,401
U54 · FY2022 · CA · contact PI
CORALE-SeroNet Project 1$366,809
U54 · FY2022 · CA · contact PI
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2$195,001
U54 · FY2022 · CA · contact PI
Admin-Core-001$195,001
U54 · FY2022 · CA · contact PI
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,936,657
U01 · FY2021 · CA
Colon Cancer Family Registry Cohort$1,894,107
U01 · FY2021 · CA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators$779,477
R01 · FY2021 · CA · contact PI
Novel Biomarkers for Cancer-Related Fatigue: Integrating Metabolomics, Genomics and Behaviors$676,985
R01 · FY2021 · NR · contact PI
Biological determinants of colorectal cancer outcomes in Latinos of diverseýancestral origins$647,843
R01 · FY2021 · CA
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2$3,386,294
U54 · FY2020 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,967,702
U01 · FY2020 · CA
Colon Cancer Family Registry Cohort$1,853,568
U01 · FY2020 · CA
CORALE-SeroNet Recruitment and Biobanking Core$939,528
U54 · FY2020 · CA · contact PI
Novel Biomarkers for Cancer-Related Fatigue: Integrating Metabolomics, Genomics and Behaviors$734,278
R01 · FY2020 · NR · contact PI
Biological determinants of colorectal cancer outcomes in Latinos of diverse ancestral origins$692,928
R01 · FY2020 · CA
CORALE-SeroNet Project 1$544,446
U54 · FY2020 · CA · contact PI
Colon Cancer Family Registry Cohort$1,985,187
U01 · FY2019 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,717,150
U01 · FY2019 · CA
Biological determinants of colorectal cancer outcomes in Latinos of diverse ancestral origins$727,816
R01 · FY2019 · CA
Colon Cancer Family Registry Cohort$2,128,492
U01 · FY2018 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,745,632
U01 · FY2018 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,839,122
U01 · FY2017 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,862,336
U01 · FY2016 · CA
Adding Hispanics to Ongoing GWAS in Colorectal Cancer$565,136
R01 · FY2015 · CA · contact PI
Adding Hispanics to Ongoing GWAS in Colorectal Cancer$786,691
R01 · FY2014 · CA · contact PI
Adding Hispanics to Ongoing GWAS in Colorectal Cancer$1,064,138
R01 · FY2013 · CA · contact PI
Adding Hispanics to Ongoing GWAS in Colorectal Cancer$1,116,233
R01 · FY2012 · CA · contact PI
Adding Hispanics to Ongoing GWAS in Colorectal Cancer$949,873
R01 · FY2011 · CA · contact PI
Pharmacogenetics of Tamoxifen and Chemotherapies and Risk of Contralateral Breast$81,041
R03 · FY2010 · CA · contact PI
Pharmacogenetics of Tamoxifen and Chemotherapies and Risk of Contralateral Breast$81,500
R03 · FY2009 · CA · contact PI